Rehovot, Israel

Eran Ophir

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations in Immunotherapy: The Contributions of Eran Ophir

Introduction

Eran Ophir is a noted inventor residing in Rehovot, Israel, recognized for his significant contributions to the field of immunotherapy. With a remarkable portfolio of seven patents, Ophir's work focuses on advanced methods for cell generation and application in transplantation and disease treatment. His innovative approaches aim to harness the body’s immune system to develop effective therapeutic solutions.

Latest Patents

Among Eran Ophir's latest innovations are two pivotal patents that enhance our understanding and application of central memory T-lymphocytes (Tcm). The first patent describes a method for generating an isolated population of cells comprising anti-third party Tcm phenotype. This process involves enriching peripheral blood mononuclear cells (PBMC) with third-party antigens alongside IL-21, followed by a culture that fosters the proliferation of cells in the absence of antigens. The resulting Tcm cells exhibit tolerance-inducing properties, which are crucial for effective transplantation and disease treatment.

In his second recent patent, Ophir discloses a genetically modified Tcm cell capable of homing to lymph nodes post-transplantation. This isolated cell, engineered to express a T cell receptor signaling module, represents a groundbreaking approach in immunotherapy, focusing on developing treatments that utilize the body's defense mechanisms against diseases.

Career Highlights

Eran Ophir currently works at Yeda Research and Development Company, which plays a vital role in advancing scientific and technological innovations. His career is marked by an impressive record of research that pushes the boundaries of medical treatments and immunological applications.

Collaborations

Throughout his career, Ophir has collaborated with esteemed colleagues, including Yaki Eidelstein and Noga Or-Geva. These partnerships have enabled the synthesis of diverse ideas and expertise, further enhancing the outcome of their research endeavors in the realm of cellular therapies and immunology.

Conclusion

Eran Ophir stands as a prominent figure in the field of immunotherapy, with his innovative patented techniques poised to make a significant impact on disease treatment and transplantation. His dedication to advancing medical science reflects the spirit of innovation that drives progress in the healthcare sector. Through his work, Ophir continues to contribute to the evolving landscape of immunological research, setting the stage for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…